Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Tekmira Pharmaceuticals Corp T.TKM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  TKMR

Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.
Price: $20.96 | Change: $-1.36 | %Change: -6.09%
Volume: 189,248 | Day High/Low: 22.96/20.88 | 52 Week High/Low: 34.66/7.61
Tekmira Pharmaceuticals Corp > TKM trading below financing price at US 28.5 or C$ 31.5
View modes: 

TKM trading below financing price at US 28.5 or C$ 31.5

- |
User avatar
4.5 stars
March 16, 2014 09:35 am

Keeping this stock for the long hawl, average entry price is 18.79.
Analysts 12 month targets around $40.
Ghosts target for this stock if plans ban out for using the technology in agriculture is no less than $100 within a couple of years.
Retirement kitty.
Rate this post
4 stars



How to invest in private equity without writing a $1 million check.

Click here to watch the video